4 studies found for:    Naurex | Phase 2
Show Display Options
Rank Status Study
1 Recruiting Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: NRX-1074 1 mg;   Drug: Placebo;   Drug: NRX-1074 5 mg
2 Not yet recruiting Open Label Extension for GLYX13-C-202, NCT01684163
Condition: Major Depressive Disorder
Intervention: Drug: GLYX-13
3 Active, not recruiting Phase 2, Double-Blind, Placebo Controlled, Randomized Withdrawal, Parallel Efficacy and Safety Study of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants During the Current Episode of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: GLYX-13;   Drug: Placebo
4 Completed Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression
Condition: Major Depressive Disorder
Intervention: Drug: GLYX-13

Indicates status has not been verified in more than two years